| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |